key: cord-0789496-ugrcnhbz
authors: Tan, Xueyun; Zhang, Shuai; Xu, Juanjuan; Zhou, Mei; Huang, Qi; Duan, Limin; Lv, Zhilei; Xia, Hui; Xiao, Wenjing; Yin, Zhengrong; Jin, Yang
title: Comparison of clinical characteristics among younger and elderly deceased patients with COVID-19: a retrospective study
date: 2020-12-11
journal: Aging (Albany NY)
DOI: 10.18632/aging.202139
sha: c65fd22e13497d452d9ce318e42424d5a91c8117
doc_id: 789496
cord_uid: ugrcnhbz

We aimed to compare the age-related clinical characteristics between younger and elderly deceased COVID-19 patients. This single-center retrospective study included 163 adult deceased COVID-19 patients who were admitted to Wuhan Union Hospital West Campus from January 12, 2020, to March 30, 2020. Demographic and clinical features were collected by reviewing the medical records. The median age of the 163 deceased patients was 69 (interquartile range [IQR], 62-78) years. They were classified as younger (age 18-69 years; 86/163, 52.8%) and elderly (≥70 years; 77/163, 47.2%) subjects. Younger deceased patients were more likely to develop fever (72/86 vs 54/77, P=0.039) than elderly deceased patients were while anorexia was (29/77 vs 19/86, P=0.029) more common in elderly deceased patients than in younger deceased patients. In multivariate analyses, age was a protective factor for acute cardiac injury of deceased COVID-19 patients (odds ratio [OR] 0.968, [95% confidence interval (CI), 0.940-0.997]; P=0.033) while chronic cardiac disease was a risk factor for acute cardiac injury of deceased COVID-19 patients (OR 2.660 [95%CI, 1.034-6.843]; P=0.042). Our study described the clinical characteristics of younger and elderly deceased COVID-19 patients and demonstrated that younger deceased patients were more likely to develop an acute cardiac injury.

Since December 2019, an ongoing outbreak of Coronavirus disease 2019 (COVID-19) has struck Wuhan, China [1] . As of August 23, 2020, COVID-19 has affected over 23 057 288 individuals in more than 200 countries, and resulted in more than 800 000 deaths worldwide [2] . The mortality rate in China was reported to be 5.45% as of August 24, 2020 [3] . However, the mortality rate of critically ill COVID-19 patients was extremely high [4] . Many studies revealed that age and comorbidities such as hypertension and chronic cardiac disease were risk factors for mortality of COVID-19 patients [5] [6] [7] [8] [9] .

Meanwhile, respiratory and cardiac complications were more frequent in non-survivors than in survivors [10] . A previous study indicated that COVID-19 patients order than 70 years old were more likely to hospitalized [11] . Another study, however, showed that age ≥ 70 was an independent risk factor for inhospital death of COVID-19 patients with diabetes [12] . However, the differences between younger and elderly COVID-19 deceased patients are still unknown. This study aimed at comparing the clinical differences between younger and elderly COVID-19 deceased patients and to provide insights on the relationship between age and death in patients with COVID-19.

The vital signs of the 163 deceased patients on admission are shown in Table 1 . The systolic blood pressure of elderly deceased patients was higher than younger deceased patients (P=0.012). However, the heart rate of younger deceased patients was faster than that of the older deceased patients (P=0.017). No significant differences were seen in any other vital signs between the two groups. The most common comorbidities in younger deceased patients were hypertension (31.4%), diabetes (18.6%), and malignancy (11.6%), while in elderly deceased patients, hypertension (46.8%), chronic cardiac disease (22.1%) and diabetes (18.2%) were most common comorbidities. Elderly deceased patients showed more presence of hypertension (36/77 vs 27/86, P=0.044), chronic obstructive pulmonary disease (COPD) (4/77 vs 0/86, P=0.048), and chronic cardiac disease (17/77 vs 8/86, P=0.024) than younger deceased patients did. The quick Sequential Organ Failure Assessment (qSOFA) score and CURB-65 pneumonia severity score were used to evaluate the severity of pneumonia in patients on admission. No significant differences were seen between younger and elderly deceased patients using the qSOFA score and CURB-65 score.

The laboratory findings of the 163 deceased patients on admission are shown in Table 2 . 138 (84.7%) patients presented with a lymphocyte count below the normal range (1.1-3.2 × 10 9 cells/L) and 97 (59.5%) patients had neutrophil count above the normal range (1.8-6.3 × 10 9 cells/L). Moreover, 153 (93.7%) patients had elevated C-reactive protein (CRP) (>8mg/L) and 145 (89.0%) patients had increased lactate dehydrogenase levels (>245U/L).

The blood eosinophil count of younger deceased patients was much lower than elderly deceased patients (P=0.019). Compared to younger deceased patients, elderly deceased patients had notably higher levels of creatinine (P=0.001), blood urea nitrogen (P=0.016), uric acid (P<0.001), myoglobin (P=0.015), and hypersensitive cardiac troponin Ι (P=0.017) than younger deceased patients did. Moreover, the activated partial thromboplastin time of elderly deceased patients was significantly longer than that of younger deceased patients (P=0.022).

Besides, a chest CT scan was conducted on 74 younger and 65 elderly deceased patients four days before or after hospitalization (Table 3) . 116 (83.5%) deceased patients showed bilateral lung involvement and 113 (81.3%) patients had a lung involvement ratio of more than 30%. The most common findings on chest CT scans were ground-glass opacity (128/139, 92.1%) and consolidation (125/139, 89.9%).

The most commonly observed complication, among the 163 deceased patients, was acute respiratory distress syndrome (ARDS) (97.5%), followed by respiratory failure (74.2%), acute cardiac injury (36.8%), septic shock (34.4%), and acute kidney injury (21.5%) ( Table  4 ). The comparison between complications in younger and elderly deceased patients is shown in Table 4 . There were no significant differences observed in complications between younger and elderly deceased patients.

Subsequently, we analyzed the factors associated with acute cardiac injury and septic shock in COVID-19 deceased patients by using a logistic regression model. In multivariable analyses, age was a protective factor for acute cardiac injury of COVID- 19 

Several studies reported that age was an independent risk factor of mortality in patients with COVID-19 [6] [7] [8] [9] 13 ]. This study found that younger deceased patients were more likely to develop fever than elderly deceased patients were. Anorexia was, however, more common in elderly deceased patients than younger deceased patients. We also found that younger deceased patients were more likely to develop an acute cardiac injury.

The mortality rate in our study was at 12.12%, which is much higher than the current national reports (4634/84981, 5.45%) [3] . This might be related to the following reasons. First, Union Hospital West Campus was a designed hospital for severely or critically ill AGING A previous study demonstrated that the infection fatality ratio for individuals 70 years and older was 10.5% while for those patients younger than 70 years was 0.43% [14] . Age-related diseases and vulnerability to COVID-19 are highly intertwined [15] . Indeed, this study showed that elderly deceased patients presented with hypertension, COPD, and chronic cardiac disease more frequently. Previous studies showed that the most commonly observed comorbidity in patients with COVID-19 was hypertension [16, 17] . This is similar to our study. However, considering that age was reported to be an independent risk factor of poor outcomes in patients with COVID-19 [6] [7] [8] [9] 13] , aging, and its related mechanisms may play an important role in disease severity of COVID-19.

The most common symptoms of the 163 deceased patients were fever, dyspnea, cough, fatigue, and shortness of breath, which were similar to other researches [18, 19] . However, in our study, fever was more frequent in younger deceased patients while anorexia was more frequent in elderly deceased patients. These results indicate that there might be some differences in disease pathogenesis and progression between the younger and elderly deceased patients. A possible hypothesis is that in critically ill COVID-19 patients, cellular hyperfunctions of elderly deceased patients were more likely to switch to cellular exhaustion, and loss of functions at late stages [15] .

The main cause of death in both groups was ARDS and respiratory failure. However, acute cardiac injury also plays an important role in in-hospital mortality in patients with COVID-19 [20] . The mechanisms of cardiac injury are however not yet well established, but are likely to involve increased cardiac stress due to respiratory failure and hypoxemia, direct myocardial infection by SARS-CoV-2, indirect injury from the systemic inflammatory response, or a combination of all three factors [21, 22] . It has been reported that SARS-CoV-2 could be detected within the myocardium of deceased patients but the presence of SARS-CoV-2 was not associated with an influx of inflammatory cells [23] . These results might suggest that myocardial injury is likely related to systemic consequences rather than direct damage caused by SARS-CoV-2 [24] . It has been reported that older COVID-19 patients were more likely to develop an acute cardiac injury [25] . However, a previous study demonstrated that cardiovascular comorbidities increased relative risks for adverse outcomes most substantially in the younger COVID-19 patients with progressively diminishing relative effects in older ages [26] . In our study, we found that age was a protective factor for the acute cardiac injury of deceased patients. These results indicated that despite the lower incidences of acute cardiac injury in younger patients, it is vital to prevent acute cardiac injury in younger patients. Moreover, once a younger patient developed an acute cardiac injury, more attention should be paid to prevent the adverse outcomes caused by the cardiac injury.

Our study had several limitations. Firstly, it was retrospective and all data was collected from case records. In addition, some important indicators such as the immunological index, and treatment history of patients were not collected in our study. Secondly, ours is a single-center study, although the health-care workers were from all over the country, hence some factors including the bacteria colonizing the hospital might be different. Thirdly, Union Hospital West Campus was a designated hospital for severely or critically ill COVID-19 patients in Wuhan, China. Consequently, there might be some selection bias, and therefore the external validity of the conclusions needs to be further validated.

In summary, this study described the clinical characteristics of younger and elderly deceased COVID-19 patients. We established that younger deceased patients were more likely to develop fever than elderly deceased patients were while anorexia was more common in elderly deceased patients than in younger deceased patients. The multivariate logistic AGING regression analysis showed that younger deceased patients were more likely to develop an acute cardiac injury. Moreover, this study demonstrated that it is important to monitor cardiac function and prevent acute cardiac injury in severely and critically ill patients with COVID-19 regardless of age. (Figure 1 ).

The diagnosis of COVID-19 was based on the guidelines of the diagnosis and treatment of new coronavirus pneumonia (version 7) published by the National Health Commission of China [27] . Acute AGING respiratory distress syndrome (ARDS) was diagnosed according to the Berlin Definition [28] . Septic shock was defined according to The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [29] . Acute kidney injury was diagnosed according to the KDIGO clinical practice guidelines [30] . Acute cardiac injury was diagnosed according to the COVID-19 rapid guideline: acute myocardial injury [31] . Patients with Brain Natriuretic Peptide (BNP) level above 250 pg/ml were also diagnosed as having a cardiac injury [32] . Acute liver injury was diagnosed as previously described [10] .

We collected all available information from the medical records in the hospital. This included the epidemiological history, clinical, laboratory, radiological characteristics, and outcomes. All data collected from electronic medical records were then recorded into a standardized form and checked by professional clinicians to verify the accuracy of the data.

Least Absolute Shrinkage and Selection Operator (LASSO) regression was applied to minimize the potential collinearity of variables measured from the same patient and over-fitting of variables as previously described [33] . In LASSO regression, the performance of the model was augmented with 10-fold cross-validation and the covariates were selected by the minimum (λ min). This regression model penalizes the absolute size of the coefficients of a regression model based on the value of λ. With larger penalties, the estimates of weaker factors shrink toward zero, so that only the strongest factors remain in the model. For respiratory failure, six variables (age, sex, COPD, hypertension, chronic cardiac disease, and diabetes) were selected to enroll into the LASSO regression model but no variables were available for further analysis. For acute cardiac injury, five variables (age, sex, hypertension, chronic cardiac disease, and diabetes) were selected to enroll into the LASSO regression model. All five variables were selected for further multivariable analysis. For septic shock, five variables (age, sex, bacterial infections, fungal infections, and diabetes) were selected to enroll into the LASSO regression model. Age, bacterial infections, and fungal infections were selected for further multivariable analysis. For acute kidney injury, six variables (age, sex, chronic kidney disease, hypertension, chronic cardiac disease, and diabetes) were selected to enroll into the LASSO regression model but no variables were available for further analysis. Other complications including liver injury and gastrointestinal bleeding were not available for multivariable analysis.

Categorical variables were presented as frequency rates and percentages, and continuous variables were expressed as mean ± standard deviation (SD) if they were normally distributed or median (interquartile range [IQR]) if they were not. Proportions for categorical variables were compared using the χ2 test or Fisher's exact test. Besides, means for continuous variables were compared using independent group t test when the data was normally distributed. Otherwise, the Wilcoxon rank-sum test was employed. A 95% confidence interval (CI) of mortality was analyzed by Wilson Score CI. All statistics were twotailed and a P value less than 0.05 was considered as significant. All statistical analyses were performed using SPSS software (version 22.0).

YJ, XT and SZ contributed to the study design. JX, LD, HX and ZY collected the epidemiological and clinical data. MZ, QH, ZL and WX summarized all data. XT and SZ performed the statistical analysis. XT, SZ and JX drafted the manuscript and supervised the entire study. All authors critically reviewed the manuscript and approved the final draft.

PMID:32015508 AGING 2. World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update

National Health Commission of the People's Republic of China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors

From causes of aging to death from COVID-19

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan

and China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

COVID-19 and cardiovascular disease

COVID-19 and the cardiovascular system

Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases

Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China

Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease

Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City

National Health Commission of China

Acute respiratory distress syndrome: the Berlin definition

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

KDIGO clinical practice guidelines for acute kidney injury

COVID-19 rapid guideline: acute myocardial injury

Brain-type natriuretic peptide and amino-terminal pro-brain-type natriuretic peptide discharge thresholds for acute decompensated heart failure: a systematic review

and China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized AGING patients with COVID-19

We thank all the patients who consented to donate their data for analysis and the medical staff members who are on the front line of caring for patients.

All authors declare that there are no conflicts of interest.

This work was supported by the National Natural Science Special Foundation of China for COVID-19 (NO.82041018) and the Independent Innovation Research Fund for Huazhong University of Science and Technology (2020kfyXGYJ).